Home

INVO BioScience, Inc. - Common Stock (INVO)

0.8330
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 3:36 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to INVO BioScience, Inc. - Common Stock (INVO)

Benchmark Holdings plc

Benchmark Holdings operates in the biotechnology sector with a focus on aquaculture health, genetics, and advanced nutrition. Their emphasis on research and development for sustainable aquaculture solutions positions them well against INVO BioScience, which focuses primarily on reproductive technologies. While both entities are in the broader biomedical space, Benchmark's established market presence and breadth in aquaculture provide them with a competitive edge in terms of investment, innovation, and market share.

CooperSurgical, Inc.

CooperSurgical supplies a wide range of medical devices and products in the field of reproductive medicine. This diversification allows them to engage in multiple aspects of fertility science, from diagnostic tools to therapeutics. In contrast, INVO BioScience’s niche focus on a more singular product line for a very specific aspect of reproduction might limit their market penetration in comparison to CooperSurgical, which can capitalize on synergies across its multiple offerings.

Fertility Focus Ltd.

Fertility Focus specializes in at-home fertility monitoring devices, which allow couples to track their fertility cycles more conveniently and accurately. This modern approach to fertility management competes with INVO BioScience's more clinical approach to reproductive assistance. Fertility Focus leverages technology innovations and consumer trends towards home-based health solutions, thus gaining traction in the market as consumers prefer convenience, presenting a competitive edge over INVO.

IVF Technology, Inc.

IVF Technology specializes in the manufacturing and supply of IVF-related products, offering services and tools essential for the in vitro fertilization process. Their technological advancements in embryo monitoring and genetic testing directly compete with INVO BioScience’s proprietary fertilization technologies. While INVO focuses on lower-cost alternatives and holistic approaches, IVF Technology's established reputation and robust product line give it an advantage in the IVF space despite INVO's innovative methods.

MediKiss Therapeutics, Inc.

MediKiss Therapeutics is focused on developing innovative therapies for various reproductive health issues, providing unique and potentially disruptive solutions to traditional methods. Their research-driven approach to reproductive health care, which encompasses a broad spectrum beyond just fertility treatments, positions them as a versatile competitor against INVO BioScience’s narrower focus on in vitro solutions. Given this wider approach, MediKiss seems to have an edge in capturing a larger share of the reproductive health market.